trial · primary record
PEGCETACOPLAN (APL-2)
Geographic Atrophy Secondary to Age-related Macular Degeneration
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 792 |
| Primary completion | 2025-09-05 |
| Primary endpoint | Number of Participants Who Experienced at Least One Ocular and Systemic Adverse Events (AEs) |
| Registry ID | NCT04770545 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:38:25.917Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04770545
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- PEGCETACOPLAN · approval
- PEGCETACOPLAN · approval
- Pegcetacoplan · compound